The Efficacy and Six-Week Tolerability of Simvastatin 80 and 160 mg/Day

Michael Davidson; Evan A. Stein; Carlos A. Dujovne; Donald B. Hunninghake; Stuart Weiss; R. Knopp; D. Roger Illingworth; Yale B. Mitchel; Michael Melino; Robert V. Zupkis; Michael R. Dobrinska; Raju D. Amin; Jonathan A. Tobert

doi:10.1016/s0002-9149(96)00742-4

Keywords

SimvastatinMedicineTolerabilityAdverse effectInternal medicineCholesterolCrossover studyLovastatinHydroxymethylglutaryl-CoA reductaseStatinCoronary artery diseaseGastroenterologyLipoproteinHMG-CoA reductaseEndocrinologyReductase

Affiliated Institutions

Center for Clinical Research (United States) US

Related Publications

Comparison of Once-Daily, niacin Extended-Release/lovastatin with standard doses of atorvastatin and simvastatin (the advicor versus other Cholesterol-Modulating agents trial evaluation [ADVOCATE])

Harold Bays , Carlos A. Dujovne , Mark E. McGovern +4 more

This study compared the relative efficacy of a once-daily niacin extended-release (ER)/lovastatin fixed-dose combination with standard doses of atorvastatin or simvastatin, with...

2003 The American Journal of Cardiology 153 citations

Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR**STELLAR = Statin Therapies for Elevated Lipid Levels compared Across doses to Rosuvastatin. Trial)

Peter H. Jones , Michael H. Davidson , Evan A. Stein +5 more

The primary objective of this 6-week, parallel-group, open-label, randomized, multicenter trial was to compare rosuvastatin with atorvastatin, pravastatin, and simvastatin acros...

2003 The American Journal of Cardiology 1382 citations

Once‐daily pravastatin in patients with primary hypercholesterolemia: A dose‐response study

Peter H. Jones , John A. Farmer , Michael D. Cressman +12 more

Abstract This multicenter, double‐blind, placebo‐controlled study was conducted to evaluate dose‐response effects and safety of once‐daily administration of pravastatin, a new i...

1991 Clinical Cardiology 65 citations

Benefits and Risks of HMG-CoA Reductase Inhibitors in the Prevention of Coronary Heart Disease A Reappraisal

Terje R. Pedersen , Jonathan A. Tobert

1996 Drug Safety 104 citations

The Cost Effectiveness of Statin Therapies in Spain in 2010, after the Introduction of Generics and Reference Prices

Pedro Plans-Rubió

2010 American Journal of Cardiovascular Drugs 31 citations

Publication Info

Year: 1997
Type: article
Volume: 79
Issue: 1
Pages: 38-42
Citations: 169
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

The Efficacy and Six-Week Tolerability of Simvastatin 80 and 160 mg/Day

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

169

OpenAlex

Cite This

APA Style

                            
                                
                                    Michael Davidson, 
                                
                                    Evan A. Stein, 
                                
                                    Carlos A. Dujovne
                                
                                et al.
                            
                            (1997). 
                            The Efficacy and Six-Week Tolerability of Simvastatin 80 and 160 mg/Day. 
                            The American Journal of Cardiology
                            , 79
                            (1)
                            , 38-42.
                            https://doi.org/10.1016/s0002-9149(96)00742-4
                        

Identifiers

DOI: 10.1016/s0002-9149(96)00742-4